TITLE

JournalScan

AUTHOR(S)
Lindsay, Alistair
PUB. DATE
May 2010
SOURCE
Heart;May2010, Vol. 96 Issue 10, p811
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article discusses the findings of a study on the comparison of the safety and efficacy of second-generation everolimus and paclitaxel-eluting stents in real-life practice.
ACCESSION #
51897281

 

Related Articles

  • Recovery from Goodpasture's Syndrome after Immunosuppressive Treatment and Plasmapheresis. Lockwood, C. M.; Boulton-Jones, J. M.; Lowenthal, R. M.; Simpson, I. J.; Peters, D. K.; Wilson, C. B. // British Medical Journal;5/3/1975, Vol. 2 Issue 5965, p252 

    Discusses the recovery of a patients with Goodpasture's syndrome after immunosuppressive treatment and plasmapheresis. Administration of an operation performed on seven occasion; Ceasure on the decline of circulating antibody levels; Definition of Goodpasture's syndrome.

  • Everolimus-eluting stents the most "economically attractive" option.  // PharmacoEconomics & Outcomes News;7/7/2012, Issue 657, p5 

    The article discusses research on the cost effectiveness of everolimus- compared with paclitaxel-eluting stents for patients undergoing percutaneous coronary revascularization by A. P. Amin and colleagues published in the May 29, 2012 issue of the "American Journal of Cardiology."

  • Immunosuppressive agents beneficial for some diseases. Kuznar, Wayne // Dermatology Times;Jul95, Vol. 16 Issue 7, p47 

    Reports on immunosuppressive agents with beneficial effects on patients with dermatologic diseases, according to Jeffrey Callen. Methotrexate; Azathioprine; Cyclosporine; Interferon alpha-2a; Intravenous immune globulin; Other therapies found to be effective in treating dermatologic diseases.

  • Pyodermatitis-Pyostomatitis Vegetans: A Clinical Course of Two Decades with Response to Cyclosporine and Low-dose Prednisolone. Brinkmeier, Thomas; Frosch, Peter J. // Acta Dermato-Venereologica;May2001, Vol. 81 Issue 2, p134 

    Pyodermatitis-pyostomatitis vegetans is a rare, polymorphous inflammatory disorder of the skin and oral mucosa first described by Hallopeau in 1898. On the skin papules, pustules and reddish brown annular vegetating plaques develop, most frequently in the intertriginous areas. In the mouth,...

  • Conservative versus immunosuppressive treatment of patients with idiopathic membranous nephropathy[sup 1]. Torres, Alvaro; Domínguez-Gil, Beatriz; Carreño, Agustín; Hernández, Eduardo; Morales, Enrique; Segura, Julian; González, Ester; Praga, Manuel // Kidney International;Jan2002, Vol. 61 Issue 1, p219 

    Conservative versus immunosuppressive treatment of patients with idiopathic membranous nephropathy.. Background: Treatment of idiopathic membranous glomerulonephritis (MGN) is a controversial issue. Whereas some authors recommend early immunosuppressive treatment of all patients with nephrotic...

  • Managing panuveitis without steroids can be difficult. Cooney, Michael J.; Jaffe, Glenn // Ophthalmology Times;09/01/99, Vol. 24 Issue 17, p18 

    Discusses the use of immunosuppressive agents as an alternative to the management of panuveitis without steroids. Information on the classes of immunosuppressive agents; Reminder after the administration of immunosuppressive drugs.

  • MMF/ATG/Steroids: An Efficient, Safe Regimen for Suboptimal Grafts.  // Kidney;Jul/Aug99, Vol. 8 Issue 4, p172 

    Evaluates the immunosuppressive effectiveness of mycophenolate mofetil and antithymocyte globulin for kidney transplant recipients of a suboptimal graft. Incidence of acute rejection and opportunistic infections in low-risk transplant recipients of a suboptimal graft; Overall patient outcome at...

  • A multicenter trial of mizoribine compared with placebo in children with frequently relapsing nephrotic syndrome. Yoshioka, Kazuo; Ohashi, Yasuo; Sakai, Tadasu; Ito, Hiroshi; Yoshikawa, Norishige; Nakamura, Hajime; Tanizawa, Takakuni; Wada, Hiroyoshi; Maki, Sunao; for the Pediatric Mizoribine Study Group In Japan; Yoshioka, K; Ohashi, Y; Sakai, T; Ito, H; Yoshikawa, N; Nakamura, H; Tanizawa, T; Wada, H; Maki, S // Kidney International;Jul2000, Vol. 58 Issue 1, p317 

    Background: The use of corticosteroids or cytotoxic/immunosuppressive agents such as cyclophosphamide, chlorambucil, and cyclosporine for the treatment of frequently relapsing nephrotic syndrome (FRNS) is limited because of their adverse effects. This study was conducted to evaluate...

  • Reversal of renal failure in nephritis associated with antibody to glomerular basement membrane. Maxwell, A.P.; Nelson, W.E.; Hill, Claire M. // BMJ: British Medical Journal (International Edition);7/30/88, Vol. 297 Issue 6644, p333 

    Reports a case on a patient with acute oliguric renal failure. Complaints of patient of hematuria and oliguria; Deterioration of renal function; Treatment with immunosuppression and plasma exchange.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics